Fingerprint
Dive into the research topics of 'Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically